AquaMed Technologies, Inc. Human Resources Contracts & Agreements
16 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Consulting Agreements (3)
- Employment Agreements (5)
- Separation Agreements (1)
- 2024 Executive Employment Agreement, dated December 26, 2023 by and between NexGel, Inc. and Adam Levy (Filed With SEC on December 29, 2023)
- 2023 Executive Employment Agreement, dated December 30, 2022 by and between NexGel, Inc. and Adam Levy (Filed With SEC on January 6, 2023)
- Executive Employment Agreement, dated November 4, 2021 by and between NexGel. Inc. and Adam Levy (Filed With SEC on November 9, 2021)
- Form of Restricted Stock Award Agreement under the AquaMed Technologies, Inc. 2019 Long-Term Incentive Plan (Filed With SEC on September 4, 2019)
- Form of Nonqualified Stop Option Agreement under the AquaMed Technologies, Inc. 2019 Long-Term Incentive Plan (Filed With SEC on September 4, 2019)
- AquaMed Technologies, Inc. 2019 Long-Term Incentive Plan (Filed With SEC on September 4, 2019)
- Form of Restricted Stock Award Agreement under 2019 Incentive Plan (Filed With SEC on March 12, 2019)
- Form of Nonqualified Stock Option Agreement under 2019 Incentive Plan (Filed With SEC on March 12, 2019)
- Form of Incentive Option Agreement under 2019 Incentive Plan (Filed With SEC on March 12, 2019)
- Form of 2019 Incentive Plan (Filed With SEC on March 12, 2019)
- Management Consulting Agreement dated October 19, 2018 between TO Pharmaceutical LLC and Seth Yakatan (Filed With SEC on March 12, 2019)
- Employment Agreement, dated as of March 9, 2016, by and between TO Pharmaceuticals LLC and Sidney Taubenfeld (Filed With SEC on March 12, 2019)
- Consulting Agreement dated as of November 1, 2018 between TO Pharmaceuticals LLC and Broom Street Associates, LLC (Filed With SEC on January 9, 2019)
- Management Consulting Agreement dated October 19, 2018 between TO Pharmaceutical LLC and Seth Yakatan (Filed With SEC on January 9, 2019)
- Employment Agreement, dated as of March 9, 2016, by and between TO Pharmaceuticals LLC and Sidney Taubenfeld (Filed With SEC on January 9, 2019)
- Form of Asset Contribution and Separation Agreement between Alliqua BioMedical, Inc. and AquaMed Technologies, Inc (Filed With SEC on January 9, 2019)
